Oxotremorine M

• Supplier: R&D Systems
• Catalog: 1067
• Prices: $115.00
• Sizes: 100 mg
• Cas Number: 3854-04-4
• Chemical Name: N,N,N-Trimethyl-4-(2-oxo-1-pyrolidinyl)-2-butyn-1-ammoniumiodide
• Formula: C11H19IN2O
• Molecular Weight: 322.19
• Purity: >98%

Product References

Cholinergic and ghrelinergic receptors and KCNQ channels in the medial PFC - Cholinergic and ghrelinergic receptors and KCNQ channels in the medial PFC

Parent MA, Amarante LM, Swanson K, Laubach M. Front Behav Neurosci. 2015 Oct 26;9:284.

Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte - Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte

Abiraman K, Pol SU, O'Bara MA, Chen GD, Khaku ZM, Wang J, Thorn D, Vedia BH, Ekwegbalu EC, Li JX, Salvi RJ, Sim FJ. J Neurosci. 2015 Feb 25;35(8):3676-88.

Muscarinic regulation of dopamine and glutamate transmission in the nucleus - Muscarinic regulation of dopamine and glutamate transmission in the nucleus

Shin JH, Adrover MF, Wess J, Alvarez VA. Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8124-9. doi:

Characterization of ST14A Cells for Studying Modulation of Voltage-Gated Calcium - Characterization of ST14A Cells for Studying Modulation of Voltage-Gated Calcium

Roberts-Crowley ML, Rittenhouse AR. PLoS One. 2015 Jul 6;10(7):e0132469.

Elimination of GRK2 from cholinergic neurons reduces behavioral sensitivity to - Elimination of GRK2 from cholinergic neurons reduces behavioral sensitivity to

Daigle TL, Caron MG. J Neurosci. 2012 Aug 15;32(33):11461-6.

Facilitation of long-term potentiation by muscarinic M(1) receptors is mediated - Facilitation of long-term potentiation by muscarinic M(1) receptors is mediated

Buchanan KA, Petrovic MM, Chamberlain SE, Marrion NV, Mellor JR. Neuron. 2010 Dec 9;68(5):948-63.

The scaffold protein NHERF2 determines the coupling of P2Y1 nucleotide and mGluR5 - The scaffold protein NHERF2 determines the coupling of P2Y1 nucleotide and mGluR5

Filippov AK, Simon J, Barnard EA, Brown DA. J Neurosci. 2010 Aug 18;30(33):11068-72.

Tonic enhancement of endocannabinoid-mediated retrograde suppression of - Tonic enhancement of endocannabinoid-mediated retrograde suppression of

Narushima M, Uchigashima M, Fukaya M, Matsui M, Manabe T, Hashimoto K, Watanabe M, Kano M. J Neurosci. 2007 Jan 17;27(3):496-506.